Change Country
Welcome to Luxembourg
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 


If you are an investor in the United Kingdom, please go to  

If you are an investor in the Netherlands, please go to  

If you are an investor in Italy, please go to  

If you are an investor in Spain, please go to  

If you are an investor in Austria, please go to  

If you are an investor in Germany, please go to   

If you are an investor in Singapore, please go to  

If you are an investor in Switzerland, please go to  

If you are an investor in Belgium, please go to  

If you are an investor in Poland, please go to 

If you are an investor in Norway, please go to

If you are an investor in Denmark, please go to

If you are an investor in Luxembourg, please go to

If you are an investor in Sweden, please go to

If you are an investor in Finland, please go to



The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.


The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:


(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.


In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 


Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.


This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.


The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.


Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 


Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 



By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Luxembourg.


By continuing to browse the site, you are agree on the use of cookies to track the number of visits.To know more about cookies policy:click here

Latest from Lyxor

Latest from Lyxor

09 Dec 2019: Trade risks loom large

Global equities fell over the week on the latest trade war developments. The US restored tariffs on steel and aluminium imports from Brazil and Argentina and imposed a USD 2.4bn levy on French imports. Further tariffs could follow after the WTO ruled against the EU in the Airbus subsidies case. High-frequency data in the US, including the manufacturing ISM were disappointing. However, strong non-farm payrolls and further pick up in wage growth suggest US economic activity remains strong. Meanwhile, factory order figures in Germany showed that machinery and car makers, a core part of the country’s industry, are suffering. There were some slight positives from China as the official manufacturing PMI ended six months of contraction, moving back above 50 to 50.2.

Next week, no changes are expected from the Fed at its upcoming FOMC meeting. In fact, the central bank is likely to maintain policy rates at their current levels over H1 2020. On Thursday the UK holds its third general election since 2015, with the Brexit crisis still unresolved. The latest polls are pointing to a Parliamentary majority for Prime Minister Johnson’s Conservative party. Meanwhile, Christine Lagarde’s first policy meeting as president of the ECB will be closely watched for indications of her leadership style and tone. China will release trade credit and inflation data next week. While Chinese trade is still being affected by higher tariffs, it should benefit from a positive base effect, and credit growth data may benefit from a seasonal pick-up.

Source: Lyxor International Asset Management. Figures reported in local currency terms. Past performance is no guide to future returns. Data as at

Our key calls

Week commencing 09/12/2019

Benefit from yield curve steepening in the US

Despite signs of weakness in the business sector, we believe US economic growth will hold up next year, supported by the resilient private sector, and we don’t expect a recession before 2021. In fact, there should be a mild cyclical recovery over H1 next year, and this would enable further steepening of the US yield curve.

Buy European equities

The risk of a hard Brexit has fallen, and while the German economy’s growth is likely to be weak in Q4 it should gain traction over the first half of next year, supported by easing uncertainty about global trade. Reduced political risks overall and a mild cyclical upswing should support further upside for broad European equity indices over the coming quarters. We maintain our preference for consumer-led sectors and industrials.

Lyxor Core STOXX Europe 600 (DR) UCITS ETF

Hold Japanese equities for the long term

We believe Japanese equities have plenty of scope to provide further strong returns over the longer term as they still look cheap on a cyclically adjusted basis. The cyclically adjusted dividend yield is currently around 1.5%, a level that has historically been consistent with future annualised returns of 13–15% (pre-dividends). This suggests it’s not too late to buy.

Things we are watching out for

The Main Event

comming soon


Coming soon...

Other major events

4 more things to put in the diary

09 Dec

DOJ report on Russia US election


FOMC meeting (with forecasts)


UK elections, ECB meeting with Lagarde


US tariff deadline 15% tariff on ~$200B

Stress-test your decision

Use our simple tools to find out how your peers are investing, how markets are performing or to determine whether an active or passive strategy is most effective in your chosen area

Hot Topics

What your peers read, the products they looked at and the tools they used most last week

These are the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists as at 23 09 2019. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/ or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to   ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees. Click here for more.